Digimed Updates
  • Home
  • SAHI Updates
  • News
  • Conference
    • ADA 2025
    • HFAI 2025
    • ATTD 2024
    • ADA 2024
    • ENDO 2022
    • ESH 2022
    • ADA 2022
    • AACE 2022
    • EASD-2021
    • HFSA-2021
    • ESC-2021
    • ADA 2021
    • ACC-2021
    • ESH-ISH-2021
    • ADA 2020
    • RSSDI 2020
    • ACC-2020
    • IDF-2019
    • EASD-2019
    • ESH-2019
    • ADA-2019
    • RSSDI-2018
    • EASD-2018
  • Specialties
    • Cardiology
    • Endocrinology
    • Conference Update
    • Other Specialties Conference
  • Subscribe
  • Contact
Select Page
Association Between Night Work and Dyslipidemia in South Korean Men and Women: A Cross-sectional Study

Association Between Night Work and Dyslipidemia in South Korean Men and Women: A Cross-sectional Study

Cardiovascular disease (CVD) is the leading cause of death in South Korea and is the cause of significant societal burdens worldwide too.

European Society of Cardiology/Heart Failure Association Position Paper on the Role and Safety of New Glucose-lowering Drugs in Patients with Heart Failure

European Society of Cardiology/Heart Failure Association Position Paper on the Role and Safety of New Glucose-lowering Drugs in Patients with Heart Failure

Type 2 diabetes mellitus (T2DM) is common (∼20–40%) in patients with heart failure (HF), and is associated with worse symptoms and quality of life, a greater burden of HF hospitalisation, and higher mortality rates compared to patients without T2DM.

Chronic Stress: A Critical Risk Factor for Atherosclerosis

Chronic Stress: A Critical Risk Factor for Atherosclerosis

As cardiovascular and cerebrovascular diseases remain a major cause of death globally, it is necessary to identify all their risk factors to improve public health and reduce their societal burden.

Mindfulness-Based Blood Pressure Reduction (MB-BP): Stage 1 Single-Arm Clinical Trial

Mindfulness-Based Blood Pressure Reduction (MB-BP): Stage 1 Single-Arm Clinical Trial

Global estimates show that a large proportion of society worldwide (31% of adults) had Stage 2 hypertension (>140/90 mmHg) in 2010.

47th Annual Meeting of Research Society for the Study of Diabetes in India, 7th-10th November 2019, JECC, Jaipur, Rajasthan (RSSDI 2019)

47th Annual Meeting of Research Society for the Study of Diabetes in India, 7th-10th November 2019, JECC, Jaipur, Rajasthan (RSSDI 2019)

The 47th Annual Meeting of the Research Society for the Study of Diabetes in India” took place in Jaipur, Rajasthan from 7-10th November. Carbon Brand Solutions was fortunate to cover a wide spectrum of international and national speakers contributing to the rich and vast content of the conference.

« Older Entries
Next Entries »
« Previous 1 2 3 4 5 6 Next »
  • Home
  • News
  • Conference
  • Subscribe
  • Contact
The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.
© 2021 Digimed India. All rights reserved.
  • Home
  • News
  • Conference
  • Subscribe
  • Contact
  • Facebook
  • Twitter
  • Google
  • Instagram
  • RSS

Designed by Elegant Themes | Powered by WordPress